Literature DB >> 9372911

Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes.

D Tantin1, A Kansal, M Carey.   

Abstract

Cockayne's syndrome (CS) is a disease characterized by developmental and growth defects, sunlight sensitivity, and a defect in transcription-coupled nucleotide excision repair. The two principle proteins involved in CS, CSA and CSB/ERCC6, have been hypothesized to bind RNA polymerase II (Pol II) and link transcription to DNA repair. We have tested CSA and CSB in assays designed to determine their role in transcription-coupled repair. Using a unique oligo(dC)-tailed DNA template, we provide biochemical evidence that CSB/ERCC6 interacts with Pol II molecules engaged in ternary complexes containing DNA and nascent RNA. CSB is a DNA-activated ATPase, and hydrolysis of the ATP beta-gamma phosphoanhydride bond is required for the formation of a stable Pol II-CSB-DNA-RNA complex. Unlike CSB, CSA does not directly bind Pol II.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372911      PMCID: PMC232536          DOI: 10.1128/MCB.17.12.6803

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Induction of the Escherichia coli lactose operon selectively increases repair of its transcribed DNA strand.

Authors:  I Mellon; P C Hanawalt
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

2.  Analysis of the signals for transcription termination by purified RNA polymerase II.

Authors:  T K Kerppola; C M Kane
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

3.  Coordinate binding of ATP and origin DNA regulates the ATPase activity of the origin recognition complex.

Authors:  R D Klemm; R J Austin; S P Bell
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

4.  Cloning and characterization of p52, the fifth subunit of the core of the transcription/DNA repair factor TFIIH.

Authors:  J C Marinoni; R Roy; W Vermeulen; P Miniou; Y Lutz; G Weeda; T Seroz; D M Gomez; J H Hoeijmakers; J M Egly
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

5.  Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography. Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody.

Authors:  N E Thompson; D B Aronson; R R Burgess
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

6.  UvrABC nuclease complex repairs thymine glycol, an oxidative DNA base damage.

Authors:  Y W Kow; S S Wallace; B Van Houten
Journal:  Mutat Res       Date:  1990-03       Impact factor: 2.433

7.  DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall.

Authors:  V A Bohr; C A Smith; D S Okumoto; P C Hanawalt
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

8.  Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IIB and IIE.

Authors:  D Reinberg; R G Roeder
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

9.  Transcription factor OTF-1 is functionally identical to the DNA replication factor NF-III.

Authors:  E A O'Neill; C Fletcher; C R Burrow; N Heintz; R G Roeder; T J Kelly
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

10.  Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene.

Authors:  I Mellon; G Spivak; P C Hanawalt
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

View more
  75 in total

Review 1.  Mechanism and regulation of transcriptional elongation by RNA polymerase II.

Authors:  D Reines; R C Conaway; J W Conaway
Journal:  Curr Opin Cell Biol       Date:  1999-06       Impact factor: 8.382

2.  A family of chromatin remodeling factors related to Williams syndrome transcription factor.

Authors:  D A Bochar; J Savard; W Wang; D W Lafleur; P Moore; J Côté; R Shiekhattar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription.

Authors:  M E Martin; A J Berk
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Translocation of Cockayne syndrome group A protein to the nuclear matrix: possible relevance to transcription-coupled DNA repair.

Authors:  Shinya Kamiuchi; Masafumi Saijo; Elisabetta Citterio; Martijn de Jager; Jan H J Hoeijmakers; Kiyoji Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

5.  Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxyl-terminal domain.

Authors:  A Mitsui; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Molecular characterization of an acidic region deletion mutant of Cockayne syndrome group B protein.

Authors:  M Sunesen; R R Selzer; R M Brosh; A S Balajee; T Stevnsner; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

Review 7.  Cockayne syndrome group B cellular and biochemical functions.

Authors:  Cecilie Löe Licht; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

8.  Initiation of DNA repair mediated by a stalled RNA polymerase IIO.

Authors:  Jean-Philippe Lainé; Jean-Marc Egly
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

Review 9.  Regulation of active genome integrity and expression by Rad26p.

Authors:  Shivani Malik; Sukesh R Bhaumik
Journal:  Nucleus       Date:  2014-10-31       Impact factor: 4.197

Review 10.  Multiple interaction partners for Cockayne syndrome proteins: implications for genome and transcriptome maintenance.

Authors:  Maria D Aamann; Meltem Muftuoglu; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Mech Ageing Dev       Date:  2013-04-09       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.